vs

Side-by-side financial comparison of McCormick & Company (MKC) and ResMed (RMD). Click either name above to swap in a different company.

McCormick & Company is the larger business by last-quarter revenue ($1.9B vs $1.4B, roughly 1.3× ResMed). ResMed runs the higher net margin — 27.6% vs 12.2%, a 15.3% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs 2.9%). Over the past eight quarters, ResMed's revenue compounded faster (7.9% CAGR vs 7.5%).

McCormick & Company, Incorporated is an American food company that manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavoring products to retail outlets, food manufacturers, and food service businesses.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

MKC vs RMD — Head-to-Head

Bigger by revenue
MKC
MKC
1.3× larger
MKC
$1.9B
$1.4B
RMD
Growing faster (revenue YoY)
RMD
RMD
+8.1% gap
RMD
11.0%
2.9%
MKC
Higher net margin
RMD
RMD
15.3% more per $
RMD
27.6%
12.2%
MKC
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.9%
7.5%
MKC

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
MKC
MKC
RMD
RMD
Revenue
$1.9B
$1.4B
Net Profit
$226.6M
$392.6M
Gross Margin
38.9%
61.8%
Operating Margin
16.8%
34.6%
Net Margin
12.2%
27.6%
Revenue YoY
2.9%
11.0%
Net Profit YoY
5.3%
13.9%
EPS (diluted)
$0.84
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MKC
MKC
RMD
RMD
Q2 26
$1.4B
Q4 25
$1.9B
$1.4B
Q3 25
$1.7B
$1.3B
Q2 25
$1.7B
$1.3B
Q1 25
$1.6B
$1.3B
Q4 24
$1.8B
$1.3B
Q3 24
$1.7B
$1.2B
Q2 24
$1.6B
$1.2B
Net Profit
MKC
MKC
RMD
RMD
Q2 26
$392.6M
Q4 25
$226.6M
$392.6M
Q3 25
$225.5M
$348.5M
Q2 25
$175.0M
$379.7M
Q1 25
$162.3M
$365.0M
Q4 24
$215.2M
$344.6M
Q3 24
$223.1M
$311.4M
Q2 24
$184.2M
$292.2M
Gross Margin
MKC
MKC
RMD
RMD
Q2 26
61.8%
Q4 25
38.9%
61.8%
Q3 25
37.4%
61.5%
Q2 25
37.5%
60.8%
Q1 25
37.6%
59.3%
Q4 24
40.2%
58.6%
Q3 24
38.7%
58.6%
Q2 24
37.7%
58.5%
Operating Margin
MKC
MKC
RMD
RMD
Q2 26
34.6%
Q4 25
16.8%
34.6%
Q3 25
16.7%
33.4%
Q2 25
14.8%
33.7%
Q1 25
14.0%
33.0%
Q4 24
17.0%
32.5%
Q3 24
17.1%
31.6%
Q2 24
14.2%
31.2%
Net Margin
MKC
MKC
RMD
RMD
Q2 26
27.6%
Q4 25
12.2%
27.6%
Q3 25
13.1%
26.1%
Q2 25
10.5%
28.2%
Q1 25
10.1%
28.3%
Q4 24
12.0%
26.9%
Q3 24
13.3%
25.4%
Q2 24
11.2%
23.9%
EPS (diluted)
MKC
MKC
RMD
RMD
Q2 26
$2.68
Q4 25
$0.84
$2.68
Q3 25
$0.84
$2.37
Q2 25
$0.65
$2.58
Q1 25
$0.60
$2.48
Q4 24
$0.79
$2.34
Q3 24
$0.83
$2.11
Q2 24
$0.68
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MKC
MKC
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$95.9M
$1.4B
Total DebtLower is stronger
$3.6B
$663.8M
Stockholders' EquityBook value
$5.7B
$6.3B
Total Assets
$13.2B
$8.5B
Debt / EquityLower = less leverage
0.63×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MKC
MKC
RMD
RMD
Q2 26
$1.4B
Q4 25
$95.9M
$1.4B
Q3 25
$94.9M
$1.4B
Q2 25
$124.1M
$1.2B
Q1 25
$102.8M
$932.7M
Q4 24
$186.1M
$521.9M
Q3 24
$200.8M
$426.4M
Q2 24
$166.3M
$238.4M
Total Debt
MKC
MKC
RMD
RMD
Q2 26
$663.8M
Q4 25
$3.6B
$403.9M
Q3 25
$3.9B
$408.7M
Q2 25
$3.9B
$658.4M
Q1 25
$3.9B
$663.1M
Q4 24
$3.9B
$662.9M
Q3 24
$3.4B
$667.6M
Q2 24
$4.1B
$697.3M
Stockholders' Equity
MKC
MKC
RMD
RMD
Q2 26
$6.3B
Q4 25
$5.7B
$6.3B
Q3 25
$5.8B
$6.1B
Q2 25
$5.6B
$6.0B
Q1 25
$5.4B
$5.5B
Q4 24
$5.3B
$5.3B
Q3 24
$5.4B
$5.2B
Q2 24
$5.3B
$4.9B
Total Assets
MKC
MKC
RMD
RMD
Q2 26
$8.5B
Q4 25
$13.2B
$8.5B
Q3 25
$13.2B
$8.3B
Q2 25
$13.2B
$8.2B
Q1 25
$12.9B
$7.6B
Q4 24
$13.1B
$7.1B
Q3 24
$13.2B
$7.2B
Q2 24
$13.0B
$6.9B
Debt / Equity
MKC
MKC
RMD
RMD
Q2 26
0.11×
Q4 25
0.63×
0.06×
Q3 25
0.67×
0.07×
Q2 25
0.69×
0.11×
Q1 25
0.71×
0.12×
Q4 24
0.73×
0.13×
Q3 24
0.63×
0.13×
Q2 24
0.77×
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MKC
MKC
RMD
RMD
Operating Cash FlowLast quarter
$542.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.39×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MKC
MKC
RMD
RMD
Q2 26
Q4 25
$542.0M
$339.7M
Q3 25
$258.8M
$457.3M
Q2 25
$45.9M
$538.8M
Q1 25
$115.5M
$578.7M
Q4 24
$458.7M
$308.6M
Q3 24
$161.7M
$325.5M
Q2 24
$163.1M
$440.1M
Free Cash Flow
MKC
MKC
RMD
RMD
Q2 26
Q4 25
$311.2M
Q3 25
$206.1M
$414.4M
Q2 25
$-2.4M
$508.2M
Q1 25
$78.4M
$557.9M
Q4 24
$288.0M
Q3 24
$102.7M
$307.7M
Q2 24
$94.8M
$415.2M
FCF Margin
MKC
MKC
RMD
RMD
Q2 26
Q4 25
21.9%
Q3 25
11.9%
31.0%
Q2 25
-0.1%
37.7%
Q1 25
4.9%
43.2%
Q4 24
22.5%
Q3 24
6.1%
25.1%
Q2 24
5.8%
33.9%
Capex Intensity
MKC
MKC
RMD
RMD
Q2 26
Q4 25
2.0%
Q3 25
3.1%
3.2%
Q2 25
2.9%
2.3%
Q1 25
2.3%
1.6%
Q4 24
1.6%
Q3 24
3.5%
1.5%
Q2 24
4.2%
2.0%
Cash Conversion
MKC
MKC
RMD
RMD
Q2 26
Q4 25
2.39×
0.87×
Q3 25
1.15×
1.31×
Q2 25
0.26×
1.42×
Q1 25
0.71×
1.59×
Q4 24
2.13×
0.90×
Q3 24
0.72×
1.05×
Q2 24
0.89×
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MKC
MKC

Consumer$1.1B61%
Flavor Solutions$723.1M39%

RMD
RMD

Segment breakdown not available.

Related Comparisons